Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the latest on COVID-19 vaccines.
Elitza Theel, Ph.D., director of Mayo Clinic's Infectious Diseases Serology Laboratory, joins this episode of the "Answers From the Lab" podcast. Dr. Theel and Bobbi Pritt, M.D., discuss advances in antibody testing for COVID-19, why this testing is important, and how it is being used.
This week’s research roundup features a study on the regulation of direct adipose tissue free fatty acid storage during mixed meal ingestion and high free fatty acid concentration conditions.
Top highlights include: contact tracing, trial vaccine update, facts about the flu, and traveling during the COVID-19 pandemic.
Looking back on their wedding, the Bashiers feel the event was a shining example of how greater empathy and understanding can be fostered between two very different cultures via a communal exchange of customs and traditions on an intimate level.
On the podcast, Dr. William Morice described how Mayo Clinic Laboratories quickly ramped up to meet pandemic testing needs.
This “Phlebotomy Webinar" will discuss the what and why of quality metrics and indicators and how to determine which indicators to monitor.
Although these sites may offer convenience, Dr. Morice cautions that it's important to understand the potential drawbacks.
Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr. Bornhorst also reviews other tests that should be used in conjunction with alpha-gal testing to accurately identify the scope and underlying cause of the allergy.
This week’s research roundup features a study on grading chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis.
Top highlights include: extended testing hours, safety during hunting seasons with COVID-19 on the rise, and should you travel for the holidays?
In a story on Washington D.C. Fox 5 News, Dr. Morice reviewed the significance of reports that a COVID-19 vaccine was found to be more than 90% effective.